PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
In mouse models, Piscidia erythrina demonstrated activity on the CNS, occupying an intermediate position between sedative and anxiolytic effects [PMID:6118937].
Evidence summary
PubMed sources
- 1.PMID: 18905805 (1948) — An investigation of Piscidia erythrina (Jamaica dogwood). · Journal of the American Pharmaceutical Association. American Pharmaceutical Association
- 2.PMID: 3174700 (1988) — Isoflavones as spasmolytic principles of Piscidia erythrina. · Progress in clinical and biological research
- 3.PMID: 6118937 (1981) — [Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them]. · Rivista di neurologia
- 4.PMID: 30495763 (1832) — On the Medical Properties of the Piscidia Erythrina, or Jamaica Dogwood. · The London medical and physical journal